After several rounds of treatment for a rare eye cancer — weekly drug infusions that could cost nearly $50,000 each — Paul Davis learned Medicare had abruptly stopped paying the bills.
Humira has been the world's best selling medicine since it arrived on the market in 2002. Now, it is finally getting competition.
The U.S. government will begin imposing penalties in 2025 on drug companies that charge its Medicare program prices that rise faster than inflation, the Centers for Medicare & Medicaid Services said on Thursday.
The Senate Judiciary Committee on Thursday advanced five bipartisan bills that aim to boost generic and biosimilar competition in the pharmaceutical marketplace by voice vote.
A wave of new treatments have cured devastating diseases. When the costs are too much, even for the insured, patients hunt for other ways to pay.
The fear started when a few patients saw their nurses and dietitians posting job searches on LinkedIn. Word spread to Facebook groups, and patients started calling Coram CVS, a major U.S. supplier of the compounded IV nutrients on which they rely for survival.
New laws target a health insurance practice called “step therapy,” which is used to control costs, but can also delay needed treatment.
Dan Brickey was stunned when he learned the news. The cost of the cystic fibrosis medicine that his 2-year-old daughter, Ali, had recently started taking was about to climb from just $180 out of pocket each year to a whopping $43,600 in 2023.
After a college student finally found a treatment that worked, the insurance giant decided it wouldn’t pay for the costly drugs. His fight to get coverage exposed the insurer’s hidden procedures for rejecting claims.
The rising price of prescription drugs has sparked outrage for more than a decade. That’s largely because medications aren’t like other expensive products.